advertisement
11.3.4 Betablocker (4)
Showing records 1 to 4
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker19270 Timolol metabolism in human liver microsomes is mediated principally by CYP2D6
Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Maenpaa J; Pelkonen O
DISPOS. Drug Metabolism and Disposition 2007; 35: 1135-1141
19375 Ocular carteolol: A review of its use in the management of glaucoma and ocular hypertension
Henness S; Harrison TS; Keating GM
Drugs and Aging 2007; 24: 509-528
19416 Allergic contact dermatitis of the eyelids from topical ophthalmic medications. The role of β-blockers: Diagnostic and management problems
Nino M; Balato N; Ayala F
Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale 2007; 61: 18-22
19258 Ocular hypotensive effect of 1% carteolol long-acting eye drops - a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product
Yamamoto T
Nippon Ganka Gakkai Zasshi 2007; 111: 463-472
